Baxter International Inc Cash Flow Conversion Efficiency
Baxter International Inc cash flow conversion efficiency. Based on the latest financial reports, Baxter International Inc (BAX) has a cash flow conversion efficiency ratio of 0.046x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($285.00 Million) by net assets ($6.18 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Baxter International Inc (BAX) total market value for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Baxter International Inc (1985–2025)
Cash flow conversion efficiency of Baxter International Inc from 1985 to 2025. This chart illustrates how Baxter International Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BAX share price today for real-time trading data and today's change.
Baxter International Inc Cash Flow Conversion Ratio Explained
Baxter International Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Baxter International Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Baxter International Inc ranked by their cash flow conversion efficiency. Review BAX free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanghai Rural Commercial Bank Co Ltd
SHG:601825
|
0.160x |
|
LATAM Airlines Group S.A.
NYSE:LTM
|
0.484x |
|
URW (STAPL.SHS CDI)EO-05
F:UBLB
|
N/A |
|
TKO Group Holdings, Inc.
NYSE:TKO
|
0.081x |
|
Eurobank Ergasias Services and Holdings S.A.
AT:EUROB
|
0.068x |
|
POWSZECHNY Z.U.ADR /1 ZY1
F:7PZ0
|
0.030x |
|
Kingspan Group plc
IR:KRX
|
0.058x |
|
Taiwan Mobile Co Ltd
TW:3045
|
0.110x |
Annual Cash Flow Conversion Efficiency for Baxter International Inc (1985–2025)
The table below shows the annual cash flow conversion efficiency of Baxter International Inc from 1985 to 2025. Also see BAX current and non-current assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $6.10 Billion | $845.00 Million | 0.138x | -4.55% |
| 2024-12-31 | $7.02 Billion | $1.02 Billion | 0.145x | -28.82% |
| 2023-12-31 | $8.47 Billion | $1.73 Billion | 0.204x | -0.78% |
| 2022-12-31 | $5.89 Billion | $1.21 Billion | 0.205x | -15.67% |
| 2021-12-31 | $9.12 Billion | $2.22 Billion | 0.244x | +13.80% |
| 2020-12-31 | $8.73 Billion | $1.87 Billion | 0.214x | -19.50% |
| 2019-12-31 | $7.91 Billion | $2.10 Billion | 0.266x | +3.71% |
| 2018-12-31 | $7.87 Billion | $2.02 Billion | 0.256x | +36.38% |
| 2017-12-31 | $9.12 Billion | $1.71 Billion | 0.188x | -5.88% |
| 2016-12-31 | $8.28 Billion | $1.65 Billion | 0.200x | -0.01% |
| 2015-12-31 | $8.87 Billion | $1.77 Billion | 0.200x | -49.32% |
| 2014-12-31 | $8.16 Billion | $3.21 Billion | 0.394x | +4.60% |
| 2013-12-31 | $8.49 Billion | $3.20 Billion | 0.377x | -15.33% |
| 2012-12-31 | $6.98 Billion | $3.11 Billion | 0.445x | +7.89% |
| 2011-12-31 | $6.83 Billion | $2.82 Billion | 0.413x | -6.63% |
| 2010-12-31 | $6.80 Billion | $3.00 Billion | 0.442x | +12.71% |
| 2009-12-31 | $7.42 Billion | $2.91 Billion | 0.392x | -2.90% |
| 2008-12-31 | $6.23 Billion | $2.52 Billion | 0.404x | +21.14% |
| 2007-12-31 | $6.92 Billion | $2.31 Billion | 0.333x | -4.24% |
| 2006-12-31 | $6.27 Billion | $2.18 Billion | 0.348x | -3.47% |
| 2005-12-31 | $4.30 Billion | $1.55 Billion | 0.361x | -3.20% |
| 2004-12-31 | $3.71 Billion | $1.38 Billion | 0.372x | -14.42% |
| 2003-12-31 | $3.27 Billion | $1.43 Billion | 0.435x | +7.22% |
| 2002-12-31 | $2.94 Billion | $1.19 Billion | 0.406x | +40.43% |
| 2001-12-31 | $3.76 Billion | $1.09 Billion | 0.289x | -34.64% |
| 2000-12-31 | $2.66 Billion | $1.18 Billion | 0.442x | +36.72% |
| 1999-12-31 | $3.35 Billion | $1.08 Billion | 0.323x | -2.20% |
| 1998-12-31 | $2.84 Billion | $939.00 Million | 0.331x | +55.24% |
| 1997-12-31 | $2.62 Billion | $558.00 Million | 0.213x | -32.72% |
| 1996-12-31 | $2.50 Billion | $793.00 Million | 0.317x | -12.20% |
| 1995-12-31 | $3.70 Billion | $1.34 Billion | 0.361x | +1.96% |
| 1994-12-31 | $3.72 Billion | $1.32 Billion | 0.354x | +47.29% |
| 1993-12-31 | $3.19 Billion | $765.00 Million | 0.240x | +19.46% |
| 1992-12-31 | $3.79 Billion | $763.00 Million | 0.201x | +14.33% |
| 1991-12-31 | $4.37 Billion | $769.00 Million | 0.176x | -9.60% |
| 1990-12-31 | $4.09 Billion | $796.00 Million | 0.195x | +33.65% |
| 1989-12-31 | $4.25 Billion | $618.00 Million | 0.146x | -34.55% |
| 1985-12-31 | $2.08 Billion | $463.00 Million | 0.222x | -- |
About Baxter International Inc
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable p… Read more